Parisa Momtaz

Personalized RNA neoantigen vaccines stimulate T cells in pancreatic cancer

Luis A. Rojas, Zachary Sethna, Kevin C. Soares et al. · Nature · 2023 · 1.3K citations · Full text

Medicine, Oncology, Pharmacology +17

Immune-Related Adverse Events, Need for Systemic Immunosuppression, and Effects on Survival and Time to Treatment Failure in Patients With Melanoma Treated With Ipilimumab at Memorial Sloan Kettering Cancer Center

Troy Z. Horvat, Nelly G. Adel, Thu-Oanh Dang et al. · Journal of Clinical Oncology · 2015 · 1.1K citations · Full text

Life Sciences, Immunology, Oncology +17

First-line pembrolizumab and trastuzumab in HER2-positive oesophageal, gastric, or gastro-oesophageal junction cancer: an open-label, single-arm, phase 2 trial

Yelena Y. Janjigian, Steven B. Maron, Walid K. Chatila et al. · The Lancet Oncology · 2020 · 357 citations · Full text

Medicine, Oncology, Pharmacotherapy +16

Neoadjuvant relatlimab and nivolumab in resectable melanoma

Rodabe N. Amaria, Michael A. Postow, Elizabeth M. Burton et al. · Nature · 2022 · 332 citations · Full text

Medicine, Oncology, Pharmacotherapy +17

Defibrotide for the Treatment of Severe Hepatic Veno-Occlusive Disease and Multiorgan Failure after Stem Cell Transplantation: A Multicenter, Randomized, Dose-Finding Trial

Paul G. Richardson, Robert J. Soiffer, Joseph H. Antin et al. · Biology of Blood and Marrow Transplantation · 2010 · 234 citations · Full text

Medicine, Hematology, Pharmacotherapy +13